Furthermore, TRAF4 knockdown decreased HER2 expression in four HER2+ breast cancer cell lines (Fig. 3B) while enhancing Trastuzumab sensitivity (Fig. 3C). The gene discussed is TRAF4; the disease is breast cancer.